Opendata, web and dolomites

CP2

CP2 is a project to develop a new wrist placement technology that can detect anomalies with both the Cardio and Vascular systems simultaneously.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CP2 project word cloud

Explore the words cloud of the CP2 project. It provides you a very rough idea of what is the project "CP2" about.

flutter    hypertension    reduce    asynchronously    paradigm    previously    draws    peripheral    owing    array    sensors    engaged    remaining    monitoring    establishment    forms    patient    screening    actively    vascular    ectopic    aortic    cardio    heart    opportunity    coat    f1    restraints    engines    subject    tested    identification    placing    utilises    shift    undetected    physiological    arterial    disease    performance    exists    seconds    locations    wrists    gone    multimodal    atrial    times    primary    data    halves    combined    diagnostic    cp2    tachycardia    hypertensive    beats    optimise    develops    works    care    syndrome    bradycardia    brings    world    operated    techniques    flow    transfers    proactive    stenosis    block    pressure    straps    sensing    circulatory    complete    technologies    equation    analyzing    incarnation    cardiac    medical    disorders    white    clothed    fibrillation    modal    motorsport    device    simultaneously    biomarkers   

Project "CP2" data sheet

The following table provides information about the project.

Coordinator
CARDIOCITY LIMITED 

Organization address
address: GROSVENOR ROAD 10
city: CARNFORTH
postcode: LA59DJ
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.cardiocity.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2014
 Duration (year-month-day) from 2014-10-01   to  2015-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIOCITY LIMITED UK (CARNFORTH) coordinator 50˙000.00

Map

 Project objective

'Combined Pressure and Cardiac Performance (CP2) is a project that develops a diagnostic device that enables a paradigm shift in physiological performance analysis. CP2 utilises multi-modal sensing to identify both Cardiac Performance as well as Vascular system performance from the subject, in 30 seconds, with the subject remaining clothed. The CP2 system draws on the experience from monitoring high performance engines within the world of F1 motorsport and transfers these techniques into medical care. By using new diagnostic sensing technologies and by analyzing the data for Biomarkers, the project is be able to identify the following disorders of the Cardio-Vascular system. Hypertension, Peripheral Arterial Disease, Aortic Stenosis, Atrial Fibrillation, Atrial Flutter, Ectopic beats, Bradycardia, Tachycardia and Type 1 & 2 Heart Block. The CP2 system works by placing an array of sensors under both wrists, with the subject actively engaged in the process. No straps or restraints are involved, the subject remains in complete control at all times throughout the process and so there is the potential to reduce 'Hypertensive White Coat' syndrome. The new multimodal sensing system allows both the Vascular and Cardio side of the Heart and Circulatory system to be tested simultaneously and the results from both halves to the equation to be reviewed against each other. The CP2 project thus brings together existing physiological parameters in new forms that should not only allow the identification of known disease, but also might lead to the establishment of biomarkers previously undetected owing to the two systems being operated asynchronously. It is easy to produce a better incarnation of what has gone before, but CP2 seeks to produce a paradigm shift in the usage of medical devices in the proactive screening role. With a screening taking only 30 seconds the opportunity exists to optimise the patient care pathway and to enhance patient flow within Primary Care locations.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CP2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CP2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More